Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicament for treating primary trigeminal neuralgia

A trigeminal neuralgia, primary technology, applied in the field of medicine, can solve the problems of large side effects, strong dependence, large dosage, etc., and achieve quick and good curative effect

Inactive Publication Date: 2015-11-18
THE AFFILIATED HOSPITAL OF QINGDAO UNIV
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, the treatment of primary trigeminal neuralgia generally depends on taking western medicine, which has large side effects and strong dependence, which leads to an increasing dose of medicine, resulting in a vicious circle

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0011] The preparation of embodiment decoction of the present invention

[0012] Take 90 grams of iron broken gong, 70 grams of pearl lotus, 70 grams of tree head vegetable, 60 grams of fragrant stone vine, 60 grams of rock broom, 50 grams of lotus flower, 50 grams of wine bottle flower, 50 grams of brocade herb, 30 grams of pheasant grass and 20 grams of sage grass, add 5000 milliliters of water, heat under reflux for 5 hours, filter, and cool the filtrate to room temperature to obtain the decoction.

experiment example

[0014] Diagnostic criteria

[0015] 1. Paroxysmal lightning-like, knife-like severe pain in the distribution area of ​​the facial trigeminal nerve, which lasts from several seconds to tens of seconds, occurs repeatedly, with the same nature, and intermittently asymptomatic;

[0016] 2. Paroxysmal pain is located in one or more branches of the trigeminal nerve distribution area on one side, and does not cross the border and invade the larynx, occipital or contralateral side;

[0017] 3. Patients often have paroxysmal pain caused by mouth and tongue movement or external stimulation, and there are often "trigger points" in the cheeks, lips, and mouth;

[0018] 4. There were no positive signs in the nervous system examination, and there was no abnormality in the sensation and masticatory muscles in the distribution area of ​​the trigeminal nerve.

[0019] Selected 160 patients who met the above diagnostic criteria, including 100 males and 60 females, aged 23-62 years, with an ave...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a medicament for curing primary trigeminal neuralgia. The medicament for curing the primary trigeminal neuralgia is prepared from the following raw materials in parts by weight: 90 parts of beesia calthifolia, 70 parts of ficus sarmentosa, 70 parts of leaf of chinese aralia, 60 parts of Schisandra lancifolia, 60 parts of herb of peltateleaf meadowrue, 50 parts of flower of japanese glorybower, 50 parts of Rhododendroa microphyton, 50 parts of phyllagathis cavaleriei, 30 parts of herb of gold stargrass and 20 parts of Boea hygrometrica. The medicament for curing the primary trigeminal neuralgia adopts natural herbs, has quick effective response and good curative effect, and is greatly suitable for curing the primary trigeminal neuralgia.

Description

[0001] The present invention is a divisional application of a patent with the application number 201510201175.3, the application date is April 26, 2015, and the invention name is "A Medicament for Treating Primary Trigeminal Neuralgia". technical field [0002] The invention relates to the field of medicine, in particular to a medicament for treating primary trigeminal neuralgia. Background technique [0003] Primary trigeminal neuralgia is caused by various lesions in the part of the trigeminal nervous system or in the adjacent parts. Symptoms of the patient's primary trigeminal neuralgia: in the distribution area of ​​the trigeminal nerve on the head and face, sudden onset, sudden arrest, lightning-like, knife-like, burning-like, intractable, unbearable severe pain, talking, washing face, Brushing your teeth or a breeze on your face, or even walking can cause episodes of severe pain that can last seconds or minutes. At present, the treatment of primary trigeminal neuralgi...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/88A61P29/00A61P25/02
Inventor 李志刚
Owner THE AFFILIATED HOSPITAL OF QINGDAO UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com